RxSight COO exercises options for 12,489 shares

RxSight, Inc. Chief Operating Officer Ilya Goldshleger exercised stock options to acquire 12,489 shares of common stock at $4.13 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

RxSight, Inc. Chief Operating Officer Ilya Goldshleger exercised stock options to acquire 12,489 shares of common stock at $4.13 per share. Following the transactions, he holds 78,180 shares directly and 1,372 shares indirectly through his spouse, indicating a routine compensation-related equity exercise with no open-market buying or selling disclosed.

Insider Trade Summary

12,489 shares exercised/converted

Exercise 3 txns

Insider Goldshleger Ilya

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	12,489	$0.00	$0.00
Exercise	Common Stock	12,489	$4.13	$52K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 5 contracts (Direct); Common Stock — 78,180 shares (Direct); Common Stock — 1,372 shares (Indirect, By spouse)

Key Figures

Options exercised: 12,489 shares Exercise price: $4.13 per share Direct holdings after exercise: 78,180 shares +3 more

6 metrics

Options exercised 12,489 shares Common stock acquired via option exercise on April 17, 2026

Exercise price $4.13 per share Stock option (right to buy) conversion price

Direct holdings after exercise 78,180 shares Common stock directly owned after April 17, 2026 transactions

Indirect holdings (spouse) 1,372 shares Common stock indirectly owned by spouse

Remaining option position 5 option shares Stock Option (right to buy) after exercise

Option expiration date April 25, 2027 Expiration of Stock Option (right to buy)

Key Terms

Stock Option (right to buy), derivative exercise/conversion, indirect ownership, Common Stock

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion""

indirect ownership financial

"ownership_type: "indirect" and nature_of_ownership: "By spouse""

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did RxSight (RXST) report for COO Ilya Goldshleger?

RxSight reported that COO Ilya Goldshleger exercised stock options to acquire 12,489 shares of common stock at $4.13 per share. After these transactions, he directly owns 78,180 shares and indirectly holds 1,372 shares through his spouse.

Did the RxSight (RXST) COO buy or sell shares on the open market?

The filing shows an option exercise, not an open-market trade. Goldshleger exercised stock options to receive 12,489 common shares at a $4.13 exercise price, with no separate reported open-market purchases or sales in this Form 4.

How many RxSight (RXST) shares does the COO own after this Form 4 filing?

After the reported transactions, COO Ilya Goldshleger directly owns 78,180 shares of RxSight common stock. The filing also reports an additional 1,372 shares held indirectly, attributed to his spouse, reflecting both direct and indirect ownership positions.

What stock option position remains for the RxSight (RXST) COO after the exercise?

The Form 4 shows a stock option labeled “right to buy” where 12,489 underlying shares were exercised, leaving 5 option shares outstanding. The option carries a $4.13 exercise price and an expiration date of April 25, 2027.

How is the spouse’s ownership reported in the RxSight (RXST) Form 4?

The filing lists 1,372 RxSight common shares as indirectly owned “by spouse.” This indicates those shares are attributed to COO Ilya Goldshleger through his spouse’s holdings, and they are reported separately from his 78,180 directly owned shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/20/2026 - 04:19 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldshleger Ilya

(Last)

(First)

(Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO

CALIFORNIA

92656

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/17/2026		M		12,489	A	$4.13	78,180	D
Common Stock								1,372	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$4.13	04/17/2026		M			12,489	04/26/2021	04/25/2027	Common Stock	12,489	$0	5	D

Explanation of Responses:

	/s/ Jim Schindler, as Attorney-in-Fact	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR